The small heat shock protein α A-crystallin is expressed in pancreas and acts as a negative regulator of carcinogenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 7-8, 2010, Pages 621-631

  Deng, Mi ^a   Chen, Pei Chao ^b   Xie, Sisi ^b   Zhao, Junqiong ^b   Gong, Lili ^a   Liu, Jinping ^a   Zhang, Lan ^a,b   Sun, Shuming ^a,b   Liu, Jiao ^a,b   Ma, Haili ^a   Batra, Surinder K ^a   Li, David Wan Cheng ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

A; AP 1; Cell migration; Lens; Pancreas; Pancreatic cancer; Smad2 3 5; Small heat shock protein; TGF

Indexed keywords

ACTIVATING PROTEIN 1; CRYSTALLIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SMALL HEAT SHOCK PROTEIN; SMALL HEAT SHOCK PROTEIN ALPHA A; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; MODULATION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ALPHA-CRYSTALLIN A CHAIN; ANIMALS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CYTOPROTECTION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAT-SHOCK PROTEINS; HUMANS; MICE; MOLECULAR WEIGHT; PANCREAS; PANCREATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 77953806476     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.04.004     Document Type: Article

References (68)

1. Benndorf R., Welsh M.J. Shocking degeneration. Nat. Genet. 2004, 36:547-548.
2. Sun Y., MacRae T.H. The small heat shock proteins and their role in human disease. FEBS J. 2005, 272:2613-2627.
3. Bennardini F., Wrzosek A., Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ. Res. 1992, 71:288-294.
4. D.W. Li, L. Gong, M. Deng, J.P. Liu, M. Liu, Y.W. Mao. The two lens structural proteins, αA- and αB-crystallins, prevent stress-induced apoptosis through regulation of multiple signaling transduction pathways. In: Arrigo, Simon (eds). Small Stress Proteins and Human Diseases. Nova Science Publisher, Inc NY, USA. chapter 1.3, pp. 27-57.
5. Benjamin I.J., Guo Y., Srinivasan S., Boudina S., Taylor R.P., Rajasekaran N.S., Gottlieb R., Wawrousek E.F., Abel E.D., Bolli R. CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3201-H3209.
6. Sherman M., Multhoff G. Heat shock proteins in cancer. Ann. N. Y. Acad. Sci. 2007, 1113:192-201.
7. Didelot C., Lanneau D., Brunet M., Joly A.L., De Thonel A., Chiosis G., Garrido C. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr. Med. Chem. 2007, 14:2839-2847.
8. Ciocca D.R., Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10:86-103.
9. Reddy G.B., Kumar P.A., Kumar M.S. Chaperone-like activity and hydrophobicity of alpha-crystallin. IUBMB Life 2006, 58:632-641.
10. Robinson M.L., Overbeek P.A. Differential expression of alpha A- and alpha B-crystallin during murine ocular development. Investig. Ophthalmol. Vis. Sci. 1996, 37:2276-2284.
11. Piatigorsky J. Lens crystallins and their genes: diversity and tissue-specific expression. FASEB J. 1989, 3:1933-1940.
12. Bhat S.P., Nagineni C.N. alpha B subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem. Biophys. Res. Commun. 1989, 158:319-325.
13. Dubin R.A., Wawrousek E.F., Piatigorsky J. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol. Cell. Biol. 1989, 9:1083-1091.
14. Kase S., Parikh J.G., Rao N.A. Expression of alpha-crystallin in retinoblastoma. Arch. Ophthalmol. 2009, 127:187-192.
15. Moyano J.V., Evans J.R., Chen F., Lu M., Werner M.E., Yehiely F., Diaz L.K., Turbin D., Karaca G., Wiley E., Nielsen T.O., Perou C.M., Cryns V.L. AlphaB-crystallin, is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J. Clin. Invest. 2006, 116:261-270.
16. Kato K., Shinohara H., Kurobe N., Goto S., Inaguma Y., Ohshima K. Immunoreactive alpha A crystallin in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim. Biophys. Acta 1991, 1080:173-180.
17. Ujiki M.B., Talamonti M.S. Surgical management of pancreatic cancer. Semin. Radiat. Oncol. 2005, 15:218-225.
18. Niederhuber J.E., Brennan M.F., Menck H.R. The National Cancer Data Base report on pancreatic cancer. Cancer 1995, 76:1671-1677.
19. Pezzilli R. Pancreatic ductal carcinoma: from the bench to the bedside. JOP 2006, 7:508-510.
20. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
21. Bardeesy N., DePinho R.A. Pancreatic cancer biology and genetics. Nat. Rev. Cancer 2002, 2:897-909.
22. Rustgi A.K. The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry. Genes Dev. 2006, 20:3049-3053.
23. Mao Y.-W., Liu J.P., Xiang H., Li D.W.-C. Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 2004, 11:512-526.
24. L. Xiao, L.-L. Gong, D. Yuan, M. Deng, J.-P. Liu, L.-L. Chen, L. Zhang, S.-M. Sun, J. Liu, X.-H. Hu, H.-L. Ma, C.-B. Zheng, H. Fu, P.-Q. Chen, J.-Q. Zhao, S.-S. Xie, X.-M. Zeng, L.-J. Zou, Y.-M. Xiao, W.-B. Liu, J. Zhang, Y. Liu, D. W.-C. Li (in press). Protein phosphatase-1 regulates Akt1 signaling pathway to control gene expression, cell survival and differentiation. Cell Death Differ. doi:10.1038/cdd.2010.16.
25. Marinov M., Ziogas A., Pardo O.E., Tan L.T., Dhillon T., Mauri F.A., Lane H.A., Lemoine N.R., Zangemeister-Wittke U., Seckl M.J., Arcaro A. AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clin. Cancer Res. 2009, 15:1277-1287.
26. Xiao Y.-M., Chen L., Liu J., Zou L.-J., Liu W.-B., Chen H.G., Liu Y., Li D.W.-C. JNK1 downregulation is associated with sex reversal of the ricefield eel. J. Exp. Zool. B. MOl. Dev. Evol. 2010, 314:242-256.
27. Feng H., Xiang H., Mao Y.-W., Wang J., Liu J.-P., Huang X.Q., Liu Y., Liu S.-J., Luo C., Zhang X.-J., Liu Y., Li D.W.-C. Human Bcl-2 activates RAF/MEK/ERK pathway and regulates AP-1 activity and downstream genes in rabbit Lens epithelial cells. Oncogene 2004, 23:7310-7321.
28. Qin J.-C., Chen H.-G., Yan Q., Deng M., Liu J.-P., Doerge S., Ma W.-Y., Dong Z., Li D.W.-C. Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates the p53-Bak apoptotic pathway. Cancer Res. 2008, 68(11):4150-4162.
29. Chen H.-G., Han W.-J., Deng M., Qin J., Yuan D., Liu J.-P., Xiao L., Gong L., Liang S., Zhang J., Liu Y., Li D.W.-C. Transcriptional regulation of PP2A-A alpha is mediated by multiple factors including AP-2alpha, CREB, ETS-1, and SP-1. PLoS One 2009, 4:e7019.
30. Li D.W.-C., Kuszak J.R., Dunn K., Wang R.-R., Ma W.-C., Wang G.-M., Spector A., Leib M., Cotliar A.M., Weiss M., Espy J., Howard G., Farris R.L., Auran J., Donn A., Hofeldt A., Mackay C., Merriam J., Mittl R., Smith T.R. Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract formation in humans and animals. J. Cell Biol. 1995, 130:169-181.
31. Li D.W.-C., Liu Jin-Ping, Wang J., Mao Y.-W., Hou Li-Hui Protein expression patterns of the signaling molecules for MAPK pathways in human, bovine and rat lenses. Investig. Ophthalmol. Vis. Sci. 2003, 44:5277-5286.
32. Li D.W.-C., Liu J.-P., Mao Y.W., Xiang H., Wang J., Ma W.-Y., Dong Z., Pike H.M., Brown Rhoderick E., Reed J.C. Calcium-activated RAF/MEK/ERK pathway mediates p53-dependent apoptosis and is abrogated by αB-crystallin through inhibition of Ras activation. Mol. Biol. Cell 2005, 16:4437-4453.
33. Chelouche-Lev D., Kluger H.M., Berger A.J., Rimm D.L., Price J.E. alphaB-crystallin as a marker of lymph node in breast carcinoma. Cancer 2004, 100:2543-2548.
34. Srinivasan A.N., Nagineni C.N., Bhat S.P. αA-Crystallin is expressed in non-ocular tissues. J. Biol. Chem. 1992, 267:23337-23341.
35. Vegh G.L., Fulop V., Liu Y., Ng S.W., Tuncer Z.S., Genest D.R., Paldi-Haris P., Foldi J., Mok S.C., Berkowitz R.S. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol. Oncol. 1999, 75:391-396.
36. Ou K., Yu K., Kesuma D., Hooi M., Huang N., Chen W., Lee S.Y., Goh X.P., Tan L.K., Liu J., Soon S.Y., Bin Abdul Rashid S., Putti T.C., Jikuya H., Ichikawa T., Nishimura O., Salto-Tellez M., Tan P. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. J. Proteome Res. 2008, 7:1518-1528.
37. Gruvberger-Saal S.K., Parsons R. Is the small heat shock protein alphaB-crystallin an oncogeneα. J. Clin. Invest. 2006, 116:30-32.
38. Curran T., Franza B.R. Fos and Jun: the AP-1 connection. Cell 1988, 55:395-397.
39. Imler J.L., Wasylyk B. AP1, a composite transcription factor implicated in abnormal growth control. Prog. Growth Factor Res. 1989, 1:69-77.
40. Varmus H.E. Oncogenes and transcriptional control. Science 1987, 238:1337-1339.
41. Durchdewald M., Angel P., Hess J. The transcription factor Fos: a Janus-type regulator in health and disease. Histol. Histopathol. 2009, 24:1451-1461.
42. Karin M., Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005, 57:283-295.
43. Leonard D.A., Rajaram N., Kerppola T.K. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4913-4918.
44. Gutierrez-Venegas G., Castillo-Aleman R. Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts. Int. Immunopharmacol. 2008, 8:1513-1523.
45. Chen D.B., Davis J.S. Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells. Mol. Cell. Endocrinol. 2003, 200:141-154.
46. Cavigelli M., Dolfi F., Claret F.X., Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 1995, 14:5957-5964.
47. Monje P., Marinissen M.J., Gutkind J.S. Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 2003, 23:7030-7043.
48. Babu G.J., Lalli M.J., Sussman M.A., Sadoshima J., Periasamy M. Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol. 2000, 32:1447-1457.
49. Arrigo A.P., Simon S., Gibert B., Kretz-Remy C., Nivon M., Czekalla A., Guillet D., Moulin M., Diaz-Latoud C., Vicart P. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 2007, 581:3665-3674.
50. Kostenko S., Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell. Mol. Life Sci. 2009, 66:3289-3307.
51. Storm F.K., Gilchrist K.W., Warner T.F., Mahvi D.M. Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas. Ann. Surg. Oncol. 1995, 2:43-48.
52. Porter W., Wang F., Duan R., Qin C., Castro-Rivera E., Kim K., Safe S. Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J. Mol. Endocrinol. 2001, 26:31-42.
53. Ciocca D.R., Stati A.O., Amprino de Castro M.M. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue. Breast Cancer Res. Treat. 1990, 16:243-251.
54. Ciocca D.R., Puy L.A., Edwards D.P., Adams D.J., McGuire W.L. The presence of an estrogen-regulated protein detected by monoclonal antibody in abnormal human endometrium. J. Clin. Endocrinol. Metab. 1985, 60:137-143.
55. Navarro D., Cabrera J.J., León L., Chirino R., Fernández L., López A., Rivero J.F., Fernández P., Falcón O., Jiménez P., et al. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J. Steroid Biochem. Mol. Biol. 1992, 41:589-596.
56. Langdon S.P., Rabiasz G.J., Hirst G.L., King R.J., Hawkins R.A., Smyth J.F., Miller W.R. Expression of the heat shock protein HSP27 in human ovarian cancer. Clin. Cancer Res. Dec 1995, 1(12):1603-1609.
57. Foster C.S., Dodson A.R., Ambroisine L., Fisher G., Møller H., Clark J., Attard G., De-Bono J., Scardino P., Reuter V.E., Cooper C.S., Berney D.M., Cuzick J. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br. J. Cancer 2009, 101:1137-1144.
58. Iwaki T., Tateishi J. Immunohistochemical demonstration of alphaB-crystallin in hamartomas of tuberous sclerosis. Am. J. Pathol. 1991, 139:1303-1308.
59. Takashi M., Katsuno S., Sakata T., Ohshima S., Kato K. Different concentrations of two small stress proteins, alphaB crystallin and HSP27 in human urological tumor tissues. Urol. Res. 1998, 26:395-399.
60. Rigas P.K., Kase S., Rao N.A. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid. Eur. J. Ophthalmol. 2009, 19:702-707.
61. Kase S., Parikh J.G., Rao N.A. Expression of alpha-crystallin in retinoblastoma. Arch. Ophthalmol. 2009, 127:187-192.
62. Kase S., Parikh J.G., Rao N.A. Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction. Br. J. Ophthalmol. 2009, 93:541-544.
63. Hruban R.H., Adsay N.V., Albores-Saavedra J., Compton C., Garrett E.S., Goodman S.N., Kern S.E., Klimstra D.S., Klöppel G., Longnecker D.S., Lüttges J., Offerhaus G.J. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 2001, 25:579-586.
64. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003, 17(2003):3112-3126.
65. Abraham S.C., Wu T.T., Klimstra D.S., Finn L.S., Lee J.H., Yeo C.J., Cameron J.L., Hruban R.H. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/-catenin pathway and chromosome 11p. Am. J. Pathol. 2001, 159:1619-1627.
66. Bardeesy N., Cheng K.-H., Berger J.H., Chu G.C., Pahler J., Olson P., Hezel A.F., Horner J., Lauwers G.Y., Hanahan D., et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006, 20(2006):3130-3146.
67. Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Fujitani Y., Fujitani S., Wright C.V.E., Moses H.L. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-signaling in cooperation with active Kras expression. Genes Dev. 2006, 20:3147-3160.
68. Pasca di Magliano M., Sekine S., Ermilov A., Ferris J., Dlugosz A.A., Hebrok M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 2006, 20(2006):3161-3173.